trial · primary record
Pociredir
Sickle Cell Disease
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 1 |
| Primary completion | 2026-07-02 |
| Primary endpoint | Number of participants reporting Treatment Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07401823 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:57.677Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07401823
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.